AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2022 Issue 4; New/Revised ICD-10-PCS Codes Section X – New Technology
Gene Expression Assay
Code XXE5X38, Measurement of infection, whole blood reverse transcription and quantitative real-time polymerase chain reaction, new technology group 8, has been created in Section X Table XXE, Measurement of Physiological Systems, to identify the gene expression assay measurement of prevalent genes in a blood specimen that correlates to a response to systemic infection and indicates the likelihood of infection-positive systemic inflammation.Body Part Approach Device/Substance/Technology Qualifier 5 Circulatory X External 3 Infection, Whole Blood Reverse Transcription and Quantitative Real-time Polymerase Chain Reaction 8 New Technology Group 8 ...
Subscribe or sign in to view the full article.
Article Overview
This article explains a coding update in ICD-10-PCS tied to a gene expression assay measurement in whole blood using reverse transcription and quantitative real-time polymerase chain reaction. It is relevant to coding professionals and clinical documentation staff who work with procedure coding updates involving infectious disease-related testing and physiological system measurement.
Why This Topic Matters
It helps readers understand that a new ICD-10-PCS entry was created for a specific laboratory-style procedure context within the Measurement of Physiological Systems section, supporting accurate code recognition and reference work.
What You Will Learn
- The general purpose of the coding update
- How the procedure is categorized within ICD-10-PCS
- The clinical context associated with the assay measurement
- How to recognize the affected table and section at a high level
Who Should Read This
- Medical coders
- Coding auditors
- Clinical documentation specialists
- Health information management professionals
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com